Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2. (2022)
Attributed to:
Structural Studies on Viruses, Viral Proteins and Cell Interactions
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7150/thno.65563
PubMed Identifier: 34987630
Publication URI: http://europepmc.org/abstract/MED/34987630
Type: Journal Article/Review
Volume: 12
Parent Publication: Theranostics
Issue: 1
ISSN: 1838-7640